1. Abraham, G.E.: Solid-phase radioimmunoassay of estradiol-17?. J. Clin. Endocrinol. Metab.29, 866 (1969)
2. Abshagen, U., Rennekamp, H., Luszpinski, G.: Pharmacokinetics of spironolactone in man. Naunyn Schmiedeberg's Arch. Pharmacol.296, 37?45 (1976a)
3. Abshagen, U., Spörl, S., Schöneshöfer, M., L'age, M., Rennekamp, H., Oelkers, W.: Influence of spironolactone endogenous steroid metabolism in man. Clin. Sci. Mol. Med.51, 307s-310s (1976b)
4. Abshagen, U.: ?-methyldigoxin disposition during spironolactone treatment. In: International Symposium on Cardiac Glycosides, Bodem, G., Dengler, H.J. (Ed.), Springer-Verlag, Berlin Heidelberg New York 1977a in press
5. Abshagen, U., Rennekamp, H., Luszpinski, G.: Disposition kinetics of spironolactone in hepatic failure after single doses and prolonged treatment. Europ. J. Clin. Pharmacol.11, 169?176 (1977b)